E-134 In-hospital complications of thrombolytic treatment for acute ischemic stroke in dialysis-dependent patients

Raymond Kai‐Yu Tong, A Wang-Selfridge, Trenton D. Colburn, Patrick M. Brauer2019 · DOI

Abstract

Intravenous thrombolysis (IVT) is a standard treatment for acute ischemic stroke (AIS), yet it remains underutilized in dialysis-dependent (DD) patients due to concerns regarding systemic health and coagulation. This study investigates the short-term in-hospital complications for DD patients receiving IVT. Utilizing the Nationwide Inpatient Sample (NIS) from 2012–2015, we found that while DD patients experience lower rates of intracerebral hemorrhage (ICH) and urinary tract infections (UTI), they face significantly higher risks of sepsis, pneumonia, and deep venous thrombosis (DVT). These findings suggest that clinical focus should shift toward aggressive infection and clot prevention to improve outcomes in this high-risk population.

Introduction

When treating acute ischemic stroke, intravenous thrombolysis is the primary pharmacological intervention to restore blood flow. However, the risk of hemorrhage often leads to the exclusion of complex patient populations from clinical trials. Patients with end-stage renal disease requiring dialysis are a particularly vulnerable group; their altered blood chemistry and systemic fragility create uncertainty for clinicians. This study aims to delineate the specific complication profile of dialysis-dependent patients to better inform risk management and clinical decision-making.

Methods

This retrospective cohort study analyzed data from the Nationwide Inpatient Sample (NIS) between 2012 and the third quarter of 2015. Using ICD-9 codes, the researchers identified adult patients (18+) admitted for AIS who received IV thrombolysis while on dialysis for renal failure.

The study isolated encounters involving specific in-hospital complications, including:

  • Intracerebral hemorrhage (ICH)
  • Pneumonia
  • Urinary tract infection (UTI)
  • Sepsis
  • Deep venous thrombosis (DVT)
  • Pulmonary embolism (PE)

Comparative analyses were performed between dialysis-dependent (DD) patients and non-dialysis (no DD) patients to assess hospital mortality, length of stay, and complication rates.

Results

The analysis included 5,745 encounters of AIS patients treated with thrombolysis while on dialysis. Among the 189 DD patients identified with complications, several significant trends emerged:

  • The ICH Paradox: DD patients had a significantly lower rate of ICH (1.1%) compared to non-DD patients (4.6%, p < 0.0001). This suggests that the primary fear of "brain bleeds" may be less prevalent in this group than previously assumed.
  • Infection Risks: Sepsis rates were nearly six times higher in the DD group (11.4% vs. 1.9%, p < 0.0001). Pneumonia was also more frequent (5.4% vs. 2.9%, p < 0.0001), though UTI rates were lower (2.5% vs. 4.2%, p < 0.0001).
  • Venous Thromboembolism: DD patients faced a substantially higher risk of DVT (15.6% vs. 3.2%, p = 0.004). There was no significant difference in the rate of pulmonary embolism (3.3% in both groups).

Discussion and Conclusion

The results highlight a distinct complication profile for dialysis-dependent stroke patients. While the lower rate of ICH is surprising given the coagulation complexities of renal failure, the heightened risk of systemic infections and venous clots is a critical clinical finding.

Physicians managing DD patients receiving IV thrombolysis should prioritize aggressive prophylaxis for pneumonia, sepsis, and DVT. Future research is needed to determine if specific thrombolytic agents (such as Tenecteplase vs. Alteplase) offer better safety profiles for this population and to investigate the physiological mechanisms behind the lower ICH rates observed in these patients. Improving short-term outcomes for dialysis-dependent patients requires a shift in focus from purely neurological monitoring to comprehensive systemic complication prevention.

Summary updated

Abstract

<h3>Background</h3> Intravenous thrombolysis remains an underutilized treatment for acute ischemic stroke (AIS) due to several relative and absolute contraindications. Previous studies have investigated outcomes for the majority of AIS patients receiving thrombolysis without including the subset of renal failure patients requiring dialysis. This study aims to investigate short-term outcomes of thrombolytic treatment for dialysis-dependent patients who suffered in-hospital complications. <h3>Methods</h3> This retrospective cohort study utilized data from the 2012–2015Q3 Nationwide Inpatient Sample (NIS). ICD-9 codes identified adult patients (ages 18+) who received thrombolytic treatment for AIS while on dialysis for renal failure, and then further isolated patients diagnosed with in-hospital complications. Complications include intracerebral hemorrhage (ICH), pneumonia, urinary tract infection (UTI), sepsis, deep venous thrombosis (DVT), and pulmonary embolism (PE). Data for patients who were missing important clinical identifiers (age, gender, race, mortality) and did not receive IV thrombolysis or dialysis were excluded. Data analyses assessed hospital mortality rate, length of stay (LOS), inpatient charges, and average age of admission. <h3>Results</h3> Of the 5,745 encounters with AIS patients treated with thrombolysis while on dialysis for renal failure, 189 dialysis-dependent patients had in-hospital complications. These patients experienced: Lower rate of ICH (1.1% DD vs. 4.6% no DD, p&lt;0.0001). Higher rate of pneumonia (5.4% DD vs. 2.9% no DD, p&lt;0.0001). Lower rate of UTI (2.5% DD vs. 4.2% no DD, p&lt;0.0001). Higher rate of sepsis (11.4% DD vs. 1.9% no DD, p&lt;0.0001). Higher rate of DVT (15.6% DD vs. 3.2% no DD, p = 0.004). No significant difference in rate of PE (3.3% DD vs. 3.3% no DD). <h3>Conclusion</h3> This study aims to inform physicians to better manage dialysis-dependent renal failure patients receiving IV thrombolysis for AIS. These patients experience lower rates of ICH and UTI, and higher rates of pneumonia, sepsis, and DVT. These findings suggest that placing clinical focus on pneumonia, sepsis, and/or DVT prevention before administering IV thrombolysis may be critical for improving short-term in-hospital outcomes for AIS. Future research should aim to investigate different thrombolytic agents to determine the optimal choice for dialysis-dependent patients with pneumonia, sepsis, and DVT, as well as delineate differences in approaches to achieve best outcomes for dialysis-dependent renal failure patients receiving IV thrombolysis. <h3>Disclosures</h3> <b>K. Tong:</b> None. <b>A. Wang-Selfridge:</b> None. <b>T. Colburn:</b> None. <b>P. Brauer:</b> None.
BibTeX
@misc{tong2019e,
  author = {Raymond Kai‐Yu Tong and A Wang-Selfridge and Trenton D. Colburn and Patrick M. Brauer},
  title = {{E-134 In-hospital complications of thrombolytic treatment for acute ischemic stroke in dialysis-dependent patients}},
  year = {2019},
  doi = {10.1136/neurintsurg-2019-snis.209},
}
Figure